TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.

Bosma, AL; Spuls, PI; Garcia-Doval, I; Naldi, L; Prieto-Merino, D; Tesch, F; Apfelbacher, CJ; Arents, BWM; Barbarot, S; Baselga, E; +19 more... Deleuran, M; Eichenfield, LF; Gerbens, LAA; Irvine, AD; Manca, A; Mendes-Bastos, P; Middelkamp-Hup, MA; Roberts, A; Seneschal, J; Svensson, Å; Thyssen, JP; Torres, T; Vermeulen, FM; Vestergaard, C; von Kobyletzki, LB; Wall, D; Weidinger, S; Schmitt, J; Flohr, C; (2019) TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema. British Journal of Dermatology, 182 (6). pp. 1423-1429. ISSN 0007-0963 DOI: https://doi.org/10.1111/bjd.18452

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/bjd.18452

Abstract

Item Type Article
PubMed ID 31444799
Elements ID 135867

Share

Download

Filename: Bosma_etal_2019_TREatment_of_ATopic_eczema.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar